JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Home・Aktien・Pulse Biosciences Inc

Pulse Biosciences Inc

Geschlossen

BrancheGesundheitswesen

15.04 7.89

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

14.01

Max

15.11

Schlüsselkennzahlen
By Trading Economics
Einkommen	-217K -19M
Verkäufe	86K 86K
EPS	-0.29
Gewinnspanne	-22,540.698
Angestellte	75
EBITDA	-228K -19M

Empfehlungen
By TipRanks
Empfehlungen	Buy
12-Monats-Prognose	+67.38% upside

Dividenden
By Dow Jones
Nächstes Ergebnis	26. März 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-179M 958M
Vorheriger Eröffnungskurs	7.15
Vorheriger Schlusskurs	15.04

Technischer Score

By Trading Central

Vertrauen

Very Strong Bearish Evidence

16.59 / 17.17 Unterstützung & Widerstand

Pulse Biosciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Feb. 2026, 22:55 UTC

Ergebnisse

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4. Feb. 2026, 21:44 UTC

Ergebnisse

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4. Feb. 2026, 21:39 UTC

Ergebnisse

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

4. Feb. 2026, 23:46 UTC

Ergebnisse

Arm Holdings Expects Slower Revenue Growth in 4Q -- Update

4. Feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4. Feb. 2026, 23:45 UTC

Heiße Aktien

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4. Feb. 2026, 23:45 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4. Feb. 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4. Feb. 2026, 22:59 UTC

Akquisitionen, Fusionen, Übernahmen

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4. Feb. 2026, 22:30 UTC

Ergebnisse

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4. Feb. 2026, 22:30 UTC

Ergebnisse

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4. Feb. 2026, 22:21 UTC

Ergebnisse

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4. Feb. 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4. Feb. 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4. Feb. 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4. Feb. 2026, 21:53 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4. Feb. 2026, 21:51 UTC

Ergebnisse

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4. Feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk

Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk

Ergebnisse

Auto & Transport Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. Feb. 2026, 21:45 UTC

Ergebnisse

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4. Feb. 2026, 21:44 UTC

Ergebnisse

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4. Feb. 2026, 21:43 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4. Feb. 2026, 21:41 UTC

Ergebnisse

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4. Feb. 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4. Feb. 2026, 21:30 UTC

Ergebnisse

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4. Feb. 2026, 21:30 UTC

Ergebnisse

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4. Feb. 2026, 21:30 UTC

Ergebnisse

Beach Energy Interim Dividend 1 Australian Cent/Sjare

4. Feb. 2026, 21:30 UTC

Ergebnisse

Steris Sees FY Adj EPS $10.15-Adj EPS $10.30 >STE

Peer-Vergleich

Kursveränderung

Pulse Biosciences Inc Prognose

Kursziel

By TipRanks

67.38% Vorteil

12-Monats-Prognose

Durchschnitt 23.5 USD 67.38%

Hoch 25 USD

Tief 22 USD

Basierend auf 2 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Pulse Biosciences Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

2 ratings

Buy

Halten

Sell

Basierend auf 2 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Pulse Biosciences Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

16.59 / 17.17Unterstützung & Widerstand

Recent bearish events outweigh bullish events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.